Kevin R. Hayes, MD

Original Contribution

Target Lesion Revascularization after Bare-Metal or Drug-Eluting Stents: Clinical Presentations and Outcomes

06/02/2010

Matthew T. Sacrinty , MPH;

Robert J. Applegate , MD;

Renato M. Santos , MD;

Sanjay K. Gandhi , MD, PhD;

Kevin R. Hayes , MD;

Michael A. Kutcher , MD, FACC, FSCAI;

William C. Little , MD;

ABSTRACT: Objective. We sought to examine the clinical presentations and subsequent clinical outcomes of patients undergoing target lesion revascularization (TLR) after either bare-metal stent (BMS) or drug-eluting stent (DES) placement....

ABSTRACT: Objective. We...

06/02/2010

Journal of Invasive Cardiology

Spotlight Interview

Spotlight Interview: CHRISTUS St. Michael Health System

09/29/2019

Nicole Fant , MSN, RN, SCRN;

Renae Temples , RN;

Kevin R. Hayes , MD;

Lisa Patterson , BS, CNMT;

Leah Harper , RT(R), ARRT;

When was the EP program started at your institution? By whom? Texarkana Cardiology Associates, in conjunction with CHRISTUS St. Michael Health System, recruited Dr. Kevin Hayes, the area’s first and only cardiac electrophysiologist, to...

When was the EP program started...

09/29/2019

EP Lab Digest